Adirondack Trust Company’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$792K Sell
9,362
-26
-0.3% -$2.1K 0.24% 80
2026
Q1
$664K Sell
9,388
-351
-4% -$26.3K 0.22% 85
2025
Q4
$769K Sell
9,739
-206
-2% -$16.3K 0.25% 79
2025
Q3
$819K Sell
9,945
-5,581
-36% -$439K 0.27% 69
2025
Q2
$1.25M Sell
15,526
-186
-1% -$14.4K 0.45% 54
2025
Q1
$1.26M Sell
15,712
-222
-1% -$18.5K 0.49% 49
2024
Q4
$1.3M Sell
15,934
-6
-0% -$499 0.5% 51
2024
Q3
$1.31M Sell
15,940
-735
-4% -$54.9K 0.51% 49
2024
Q2
$1.17M Sell
16,675
-101
-0.6% -$7.21K 0.48% 52
2024
Q1
$1.24M Sell
16,776
-190
-1% -$13.2K 0.52% 50
2023
Q4
$1.18M Sell
16,966
-173
-1% -$10.8K 0.51% 52
2023
Q3
$1.08M Buy
17,139
+40
+0.2% +$2.49K 0.54% 48
2023
Q2
$1.08M Buy
17,099
+327
+2% +$18.1K 0.5% 50
2023
Q1
$972K Sell
16,772
-42
-0.2% -$2.83K 0.49% 51
2022
Q4
$1.22M Buy
16,814
+278
+2% +$19.9K 0.63% 38
2022
Q3
$1M Buy
16,536
+135
+0.8% +$8.62K 0.56% 43
2022
Q2
$1.03M Buy
16,401
+391
+2% +$25.9K 0.55% 42
2022
Q1
$1.13M Buy
16,010
+2,984
+23% +$202K 0.53% 46
2021
Q4
$814K Sell
13,026
-190
-1% -$11.9K 0.39% 64
2021
Q3
$830K Buy
13,216
+179
+1% +$10.8K 0.39% 64
2021
Q2
$780K Sell
13,037
-40
-0.3% -$2.54K 0.39% 64
2021
Q1
$795K Buy
13,077
+1,395
+12% +$77K 0.42% 62
2020
Q4
$562K Sell
11,682
-450
-4% -$19.5K 0.34% 66
2020
Q3
$451K Sell
12,132
-160
-1% -$6.07K 0.3% 70
2020
Q2
$465K Sell
12,292
-664
-5% -$23.1K 0.31% 68
2020
Q1
$396K Buy
12,956
+2,130
+20% +$94.4K 0.32% 69
2019
Q4
$538K Buy
10,826
+1,332
+14% +$64.3K 0.35% 62
2019
Q3
$448K Sell
9,494
-162
-2% -$7.72K 0.31% 67
2019
Q2
$479K Buy
9,656
+295
+3% +$13.9K 0.33% 61
2019
Q1
$432K Buy
9,361
+1,165
+14% +$51.5K 0.3% 68
2018
Q4
$337K Buy
8,196
+256
+3% +$11K 0.26% 71
2018
Q3
$371K Sell
7,940
-287
-3% -$13.1K 0.25% 73
2018
Q2
$359K Buy
8,227
+110
+1% +$5.13K 0.25% 72
2018
Q1
$387K Buy
8,117
+1,997
+33% +$96.9K 0.28% 68
2017
Q4
$309K Buy
6,120
+70
+1% +$3.69K 0.22% 77
2017
Q3
$314K Sell
6,050
-738
-11% -$35.9K 0.25% 71
2017
Q2
$332K Sell
6,788
-5,028
-43% -$233K 0.27% 70
2017
Q1
$556K Sell
11,816
-2,176
-16% -$104K 0.39% 59
2016
Q4
$672K Sell
13,992
-563
-4% -$25.8K 0.47% 54
2016
Q3
$577K Buy
14,555
+780
+6% +$29.3K 0.42% 61
2016
Q2
$489K Buy
13,775
+102
+0.7% +$3.98K 0.35% 62
2016
Q1
$536K Buy
13,673
+146
+1% +$5.46K 0.4% 59
2015
Q4
$539K Buy
13,527
+220
+2% +$9.67K 0.43% 59
2015
Q3
$559K Sell
13,307
-426
-3% -$19.9K 0.45% 57
2015
Q2
$685K Buy
13,733
+701
+5% +$33.2K 0.51% 51
2015
Q1
$587K Buy
13,032
+1,161
+10% +$52.2K 0.44% 58
2014
Q4
$572K Buy
11,871
+528
+5% +$25.1K 0.43% 58
2014
Q3
$543K Sell
11,343
-455
-4% -$22.1K 0.41% 59
2014
Q2
$584K Buy
11,798
+701
+6% +$32.8K 0.45% 55
2014
Q1
$522K Sell
11,097
-476
-4% -$21.9K 0.42% 58
2013
Q4
$556K Sell
11,573
-113
-1% -$5.07K 0.45% 56
2013
Q3
$489K Sell
11,686
-673
-5% -$29K 0.43% 58
2013
Q2
$504K Buy
+12,359
New +$454K 0.46% 53

Other funds holding MET

Adirondack Trust Company's MET Position: Q2 2026 in Review

Adirondack Trust Company reduced its MetLife (MET) stake by 0.28% in Q2 2026, selling an estimated $2.1K and leaving 9,362 shares worth $792K. The position accounts for 0.24% of the portfolio, ranked #80.

Adirondack Trust Company first reported a position in MET in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.31M in Q3 2024. 1,440 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • Adirondack Trust Company held 9,362 shares of MetLife worth $792K as of Q2 2026.
  • Adirondack Trust Company sold 26 MetLife shares in Q2 2026, an estimated $2.1K.
  • MetLife made up 0.24% of Adirondack Trust Company's portfolio in Q2 2026, its #80 holding.
  • Adirondack Trust Company first reported a position in MetLife in Q2 2013 and has held it in 53 quarters since.
  • Adirondack Trust Company's MetLife position peaked at $1.31M in Q3 2024.
  • 1,440 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.